Press release
October 28, 2026
Kymera Therapeutics to Announce KT-579 Phase 1 Healthy Volunteer Trial Results on October 29, 2026
Kymera Therapeutics, Inc. (KYMR)
We couldn't retrieve the full text for this release. Read it on the company's site.